LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma.

Zhou, Yuqiang; Huan, Lin; Wu, Yangjun; Bao, Chunyang; Chen, Bing; Wang, Lu; Huang, Shenglin; Liang, Linhui; He, Xianghuo

Zhou, Yuqiang; Huan, Lin; Wu, Yangjun; Bao, Chunyang; Chen, Bing; Wang, Lu; Huang, Shenglin; Liang, Linhui; He, Xianghuo.

Afiliación

Zhou Y; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Huan L; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Wu Y; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Bao C; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Chen B; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Wang L; Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, 270 Dong an Road, Shanghai, 200032, China.
Huang S; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Liang L; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. Electronic address: lianglinhui@fudan.edu.cn.
He X; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. Electronic address: xhhe@fudan.edu.cn.

Cancer Lett ; 469: 399-409, 2020 01 28.

Article en En | MEDLINE | ID: mdl-31730902

Asunto(s)

Carcinoma Hepatocelular/genética; Histona Desacetilasas/genética; Proteína 2 Inhibidora de la Diferenciación/genética; Neoplasias Hepáticas/genética; ARN Largo no Codificante/genética; Proteínas Represoras/genética; Adulto; Anciano; Carcinoma Hepatocelular/patología; Movimiento Celular/genética; Proliferación Celular/genética; Supervivencia sin Enfermedad; Transición Epitelial-Mesenquimal/genética; Femenino; Regulación Neoplásica de la Expresión Génica/genética; Células Hep G2; Humanos; Estimación de Kaplan-Meier; Neoplasias Hepáticas/patología; Masculino; Persona de Mediana Edad; Metástasis de la Neoplasia; Transducción de Señal/genética

Palabras clave

EMT; HCC; HDAC8; ID2; ID2-AS1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Represoras / Carcinoma Hepatocelular / Proteína 2 Inhibidora de la Diferenciación / ARN Largo no Codificante / Histona Desacetilasas / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Lett Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google